Pernix Therapeutics Holdings, Inc.
(NASDAQ : PTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
0.09%181.020.4%$209.60m
AMRNAmarin Corporation Plc Sponsored ADR
0.23%15.422.0%$194.62m
PRGOPerrigo Co. Plc
-3.10%63.366.8%$106.38m
JAZZJazz Pharmaceuticals Plc
-5.51%142.392.2%$102.55m
ENDPEndo International Plc
-4.51%12.918.9%$66.31m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-3.15%128.026.3%$63.31m
MNKMallinckrodt Plc
0.29%31.1621.1%$55.91m
SAGESAGE Therapeutics, Inc.
-2.40%106.419.6%$51.52m
ICPTIntercept Pharmaceuticals, Inc.
-6.58%94.0918.7%$46.10m
HZNPHorizon Pharma plc
-2.11%21.397.4%$45.50m
UTHRUnited Therapeutics Corporation
-1.58%110.9414.4%$43.00m
CTLTCatalent Inc
-1.18%37.772.4%$36.07m
PTLAPortola Pharmaceuticals, Inc.
-3.98%19.287.7%$34.46m
ICLRICON Plc
-1.06%136.534.1%$34.19m
AERIAerie Pharmaceuticals, Inc.
-6.12%40.676.9%$26.90m

Company Profile

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ.